Dopaminergic and cholinergic control of argininevasopressin secretion in type I diabetic men (Q72015037)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7656919%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Dopaminergic and cholinergic control of arginine-vasopressin secretion in type I diabetic men (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7656919%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Dopaminergic and cholinergic control of argininevasopressin secretion in type I diabetic men (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

23 July 2024

author name string

V. Coiro

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7656919

23 July 2024

R. Volpi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7656919

23 July 2024

L. Capretti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7656919

23 July 2024

R. Colla

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7656919

23 July 2024

G. Caffarri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7656919

23 July 2024

P. P. Vescovi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7656919

23 July 2024

P. Chiodera

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7656919

23 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7656919

23 July 2024

publication date

1 June 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7656919%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

22 October 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2362.1995.tb01722.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2362.1995.tb01722.x

23 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

European Journal of Clinical Investigation

23 July 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7656919%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7656919%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7656919%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

412-417

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7656919%20AND%20SRC:MED&resulttype=core&format=json

Possible altered dopaminergic modulation of pituitary function in normal-menstruating women with insulin dependent diabetes mellitus (IDDM)

22 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

Abnormal conjugated dopamine levels in patients with normoprolactinaemic amenorrhoea and in insulin-dependent diabetic patients

23 July 2024

2

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

TSH and PRL responses to domperidone and TRH in men with insulin-dependent diabetes mellitus of different duration

23 July 2024

3

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

Reduced sensitivity to pirenzepine-induced blockade of growth hormone responses to arginine, exercise, and growth hormone-releasing hormone in type I diabetic subjects

23 July 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

Apomorphine in the evaluation of dopaminergic function in man.

23 July 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

Differential effects of aging on neuroendocrine responses to physostigmine in normal men.

23 July 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

Apomorphine-induced nausea in humans: release of vasopressin and pancreatic polypeptide

23 July 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

Responses of plasma oxytocin and arginine vasopressin to nausea induced by apomorphine and ipecacuanha

23 July 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

Influence of the emetic reflex on vasopressin release in man

23 July 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

Simultaneous radioimmunoassay for plasma arginine-vasopressin and oxytocin using DEAE Sephadex A 25 extraction

23 July 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

Arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in type 1 (insulin-dependent) diabetes

23 July 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

Abnormal arginine-vasopressin responses to metoclopramide and insulin-induced hypoglycemia in type I diabetes mellitus

23 July 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

Nicotinic-cholinergic involvement in arginine-vasopressin response to insulin-induced hypoglycemia in normal men

23 July 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

Pancreatic and pituitary hormonal responses to insulin-induced hypoglycaemia during muscarinic cholinergic blockade in man

23 July 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

Muscarinic cholinergic, but not serotoninergic mediation of arginine vasopressin response to metoclopramide in man.

23 July 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

Osmotic and nonosmotic control of vasopressin release in the elderly: effect of metoclopramide

23 July 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

The effect of bromocriptine on circulating vasopressin

23 July 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

Central nervous system mediators of vasopressin release

23 July 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

Neurophysiology and neuropharmacology of hypothalamic magnocellular neurons secreting vasopressin and oxytocin

23 July 2024

22

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

Comparison of the effect of apomorphine and L-DOPA on serum growth hormone levels in normal men

23 July 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

Apomorphine increases plasma oxytocin concentration in male rats

23 July 2024

24

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1995.TB01722.X

23 July 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7656919%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference